GBS Inc. (GBS)의 가격은 얼마입니까?

GBS Inc. (GBS)의 가격은 $0.4732입니다.

GBS Inc. (GBS)의 시가 총액은 무엇입니까?

GBS Inc. (GBS)의 시가 총액은 $7.05M입니다.

GBS Inc. (GBS) 영업이익률

Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

연도	영업이익률	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

영업이익률

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	영업이익률	영업이익률 차이	국가
Abbott Laboratories ABT.US	17.03%	-	US
Stryker Corporation SYK.US	22.03%	-	US
Medtronic plc MDT.US	17.86%	-	IE
Boston Scientific Corporation BSX.US	21.46%	-	US
Edwards Lifesciences Corporation EW.US	28.09%	-	US

회사

영업이익률

영업이익률 차이

국가